GOLM1 and HIF1a form a positive inter-regulatory loop to promote the metastasis and sorafenib resist

来源 :2019中国肿瘤学大会 | 被引量 : 0次 | 上传用户:yadnlf
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective Solid tumors are characterized by containing poorly vascularized regions(hypoxia)which are typically associated with poor clinical outcomes,like tumor recurrence,metastasis and chemotherapy resistance.
其他文献
Objective Follicular variant papillary thyroid carcinoma(FVPTC)is included in the class of differentiated thyroid cancer and is currently treated as classical variant papillary thyroid carcinoma(cPTC)
目的 针对前期通过Cell-SELEX(全细胞指数富集的配基进化系统)方法,筛选获得靶向前列腺癌骨转移的特异性核酸适配体AIA1和AIA2进行体外体内功能学检测。明确特异性核酸适配体与紫杉醇协同有望成为前列腺癌转移治疗的新方法。
Objective Aberrant expression of μ-opioid receptor(MOR)has been reported to be involved in tumor malignancy and cancer tumorigenic process.
Objective Previously,we found that c-jun was highly expressed in radiation resistant human nasopharyngeal carcinoma cells(CNE-2R)compared to human nasopharyngeal carcinoma cells(CNE-2).
目的 分析首诊Ⅳ期乳腺癌患者的临床病理特征,探讨并评估外科治疗与生存相关性及其对预后的影响因素。方法 收集2007年3月至2016年11月就诊于河北省沧州中西医结合医院及天津肿瘤医院初治为Ⅳ 期的乳腺癌患者的临床资料共138 例。
Objective Nearly half of bladder cancer(BC)patients that present with locally advanced disease have occult distant metastases at presentation and poor 5-year survival rate.
目的 上皮间质转换(epithelial-mesenchymal transition,EMT)使得肿瘤细胞转变成为具有侵袭性和转移性的间质细胞表型,获得较强的迁移能力.Numb 分子在多种肿瘤组织中表达改变,且越来越多的证据表明Numb 是调解EMT 过程的重要分子,但Numb 通过调节EMT 过程在结肠癌细胞侵袭及转移中的作用目前还不清楚.
目的 长链非编码RNA MALAT1(LncRNA MALAT1)在头颈部鳞癌中异常表达,探索LncRNA MALAT1影响头颈部鳞癌生长侵袭的具体作用和机制。方法 原位杂交和免疫组化分别检测并LncRNA MALAT1 和VHL 在头颈部鳞癌中的表达情况和表达相关性,GEO 数据库分析LncRNA MALAT1 和VHL 在头颈部鳞癌中的表达及相关性;利用小干扰RNA 敲低LncRNA MALA
Objective The phosphorylation of EphA2 at serine 897(pS897-EphA2)plays a key role in the ligand-independent functions of EphA2.The ligand-independent promotion of cancer cell migration and invasion by
Objective EphA2 and interleukin-6(IL6)have been implicated in cancer metastasis and stem properties,but the link between EphA2 and IL6 in cancer is unknown.